Avène Thermal Spring Cleanance Comedomed Acne-prone Skin 30ml

Cleanance Comedomed, an innovation from Eau Thermale Avène Laboratories with proven clinical efficacy from seven days*, fights pimples from the root and limits their reappearance. An expert treatment for oily, acne-prone skin, Cleanance Comedomed is formulated with Comedoclastin™, a plant extract from milk thistle seeds. This active ingredient with patented properties** directly targets micro-comedones, reduces existing pimples and blackheads and limits the appearance of new ones, and regulates the hyperproduction of sebum. Cleanance Comedomed is suitable for adults and adolescents from the age of 12, applied twice a day, morning and evening, and offers clinically proven anti-recurrence action***. Non-comedogenic, high tolerance* for acne-prone skin, its fast-absorbing texture with a non-greasy finish leaves the skin mattified._x000D_ _x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_** Patent pending. _x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects , two applications per day of Cleanance Comedomed for six months. • EFFECTIVE: on all types of imperfections in acne-prone skin, thanks to Comedoclastin™**, which acts at the root of pimples to reduce them and limit their appearance. _x000D_• FAST: reduces pimples in seven days*. Prevent their recurrence***. For clearer skin and better daily comfort._x000D_• VERY WELL TOLERATED: used alone or in combination with medicinal treatments (excluding oral isotretinoin), its tolerance by sensitive acne-prone skin has been clinically demonstrated*. _x000D__x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, two applications per day of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. _x000D_• VERY WELL TOLERATED: used alone or in combination with medicinal treatments (excluding oral isotretinoin), its tolerance by sensitive acne-prone skin has been clinically demonstrated*. _x000D__x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, two applications per day of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. _x000D_• VERY WELL TOLERATED: used alone or in combination with medicinal treatments (excluding oral isotretinoin), its tolerance by sensitive acne-prone skin has been clinically demonstrated*. _x000D__x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, two applications per day of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. its tolerance by sensitive acne-prone skin has been clinically demonstrated*. _x000D__x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, two applications per day of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. its tolerance by sensitive acne-prone skin has been clinically demonstrated*. _x000D__x000D_*Tolerance and efficacy study under dermatological control on 51 subjects, use of Cleanance Comedomed twice a day for 56 days._x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, two applications per day of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. _x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, twice daily applications of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days. _x000D_**Patent pending._x000D_***International observational clinical study, 90% of patients without relapse of acne at T6 months, (according to the definition of relapse of the GEA protocol ≥3 requiring the introduction of drug treatment – ​​oral or local), 48 subjects, twice daily applications of Cleanance Comedomed for six months. Effectiveness demonstrated from 7 days.